HIV Prevention Trials Network (HPTN)

The HIV Prevention Trials Network develops and tests the safety and efficacy of primarily non-vaccine interventions designed to prevent the transmission of HIV.

Main Areas of Focus

  • To discover and develop new and innovative research strategies to reduce the acquisition and transmission of HIV

Oversight

The Executive Committee is made up of: Principal Investigators (PIs), International Lead Investigator, Past PI and Co-PI, SDMC PI & LC PI,  LOC Director, Community Representative, two NIH Representatives, and two Site Representatives.

Locations

HPTN has 90 clinical research sites in more than 15 countries around the world.

 

Events

HPTN holds an annual meeting as well as regular regional meetings.

 

Related Resources
Content last reviewed on November 17, 2017